Aspiration Risk, Identified. Pneumonia, Prevented.
Aspira Medical was founded to address a blind spot in critical care. Aspiration pneumonia remains one of the most common and deadly ICU complications, yet risk is often identified only after patients show signs of infection.
Silent aspiration is a frequent but underdiagnosed complication in ICU patients.
THE CHALLENGE
It affects 17% of ICU patients, carries a 30% mortality rate, and drives over $15 billion in additional healthcare costs each year.
Despite its prevalence, there is no standard for real-time aspiration risk detection. Clinicians are often left to react only after pneumonia has already developed. Existing tools—like intermittent gastric checks or imaging—are delayed, indirect, and ineffective for early intervention.
Aspiration pneumonia is preventable. The problem is, we’ve been catching it too late.
Aspira Medical offers a new standard in aspiration risk detection.
THE SOLUTION
Our non-invasive wearable continuously monitors relevant physiological signals and notifies care teams when aspiration risk is rising—giving them the opportunity to intervene before pneumonia develops.
Designed for ease of use and ICU integration, our disposable, low-cost patch provides continuous, real-time data without disrupting workflows. With Aspira, hospitals can move from reactive care to proactive aspiration management, enhancing patient safety and improving outcomes.